The purpose of the award is to recognize individuals who have devoted their career to oligonucleotide medicine and are an outstanding example to young or new members of the field. Such individuals may have made this contribution through one, or many, of the following descriptions:
- An individual who has made a significant scientific contribution to the field of oligonucleotide medicine, over decades, by means of multiple high impact publications, leadership in the oligonucleotide community, and mentorship to trainees
- An individual who has made an exceptional scientific contribution to the field of oligonucleotide medicine through the publication of one (or more) revolutionary papers which have made an immediate and significant contribution to the field of oligonucleotide medicine
- An individual who has played a critical role, over decades, guiding decisions at companies and/or in academia and who might not be identified with any one scientific discovery
- An individual who has played a critical role, over decades, in the leadership and/or mentorship or a prolific group of scientists (trainees)
- The BOD require that each nomination is supported by at least one letter of recommendation which addresses how the nominee represents the essence of the award. Applicants falling into the categories of emeritus, academic professional (minimally at the rank of assistant professor), or industry professional can be nominated. It is not required that the nominee be a member of the OTS or that they be currently active in research, however they must be able to attend the annual meeting to receive their prize and deliver a lecture.
- Nomination deadlines will be announced for the 2022 Awardee cycle.